Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Dosing in Diabetic ACS Patients
NCT05293808Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- May 2014
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin in acute coronary syndrome (ACS) (3 arms), sponsored by University of Naples Federico II. Primary endpoint: Effects of different doses of aspirin on platelet aggregation at 1 month. Started May 2014; status: completed.
02
Drugs
aspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT05293808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05293808.